Suppliers / Duchesnay

Duchesnay

Canada 84 employees 2 duplicate records merged Updated 9 July 2026

Duchesnay is a finished-dose manufacturer based in Canada. It appears in 32 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, US FDA and ARCSA (EC). Its GMP standing is certified by MFDS (Korea), US FDA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 27 October 2023 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
32
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 27 October 2023 VAI US FDA
  • 29 March 2019 VAI US FDA
  • 25 February 2016 NAI US FDA
  • 22 August 2013 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
BLAINVILLE, United Arab Emirates Not on file
QUEBEC, Canada Not on file
Canada, Canada 3009166000

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 27 None
US FDA 2 1
ARCSA (EC) 1 None
INVIMA (CO) 1 None
EMA 1 None
MFDS (Korea) None 2
ANVISA (Brazil) None 1

Comparing suppliers?

Choose your molecules and target markets. Duchesnay comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 27 October 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates